Literature DB >> 22835470

An ongoing large outbreak of measles in Merseyside, England, January to June 2012.

R Vivancos1, A Keenan, S Farmer, J Atkinson, E Coffey, E Dardamissis, J Dillon, R J Drew, M Fallon, R Huyton, R Jarvis, G Marsh, R Mason, T Shryane, A Stewart, S Ghebrehewet.   

Abstract

From 1 January to 30 June 2012, 359 confirmed and 157 probable cases of measles were reported in Merseyside, England. The most affected age groups were children under five years and young adults from 15 years of age. Most cases have been sporadic. There have been few outbreaks in nurseries; however, no outbreaks have been reported in schools. Of the cases eligible for vaccination, only 3% of the confirmed cases were fully immunised.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22835470     DOI： 10.2807/ese.17.31.20234-en

Source DB:  PubMed          Journal:  Euro Surveill        ISSN： 1025-496X


  18 in total

1.  An assessment of measles vaccine effectiveness, Australia, 2006-2012.

Authors:  Alexis Pillsbury; Helen Quinn
Journal:  Western Pac Surveill Response J       Date:  2015-07-09

2.  Sustained outbreak of measles in New South Wales, 2012: risks for measles elimination in Australia.

Authors:  Zeina Najjar; Kirsty Hope; Penelope Clark; Oanh Nguyen; Alexander Rosewell; Stephen Conaty
Journal:  Western Pac Surveill Response J       Date:  2015-01-30

3.  Epidemiology of two large measles virus outbreaks in Catalonia: what a difference the month of administration of the first dose of vaccine makes.

Authors:  Núria Torner; Andres Anton; Irene Barrabeig; Sara Lafuente; Ignasi Parron; César Arias; Neus Camps; Josep Costa; Ana Martínez; Roser Torra; Pere Godoy; Sofia Minguell; Glòria Ferrús; Carmen Cabezas; Ángela Domínguez
Journal:  Hum Vaccin Immunother       Date:  2013-01-09       Impact factor: 3.452

4.  Tumour immunogenicity, antigen presentation and immunological barriers in cancer immunotherapy.

Authors:  David Escors
Journal:  New J Sci       Date:  2014-01-05

5.  Measles outbreak spreading from the community to an anthroposophic school, Berlin, 2011.

Authors:  S Gillesberg Lassen; M Schuster; M Stemmler; A Steinmüller; D Matysiak-Klose; A Mankertz; S Santibanez; O Wichmann; G Falkenhorst
Journal:  Epidemiol Infect       Date:  2013-07-03       Impact factor: 4.434

Review 6.  Evolving measles status and immunization policy development in six European countries.

Authors:  Ivo Vojtek; Heidi Larson; Stanley Plotkin; Pierre Van Damme
Journal:  Hum Vaccin Immunother       Date:  2022-02-18       Impact factor: 4.526

7.  The changing epidemiology of measles in an era of elimination: lessons from health-care-setting transmissions of measles during an outbreak in New South Wales, Australia, 2012.

Authors:  Alexis Pillsbury; May Chiew; Shopna Bag; Kirsty Hope; Sophie Norton; Stephen Conaty; Vicky Sheppeard; Peter McIntyre
Journal:  Western Pac Surveill Response J       Date:  2016-10-19

Review 8.  Modulating Vaccinia Virus Immunomodulators to Improve Immunological Memory.

Authors:  Jonas D Albarnaz; Alice A Torres; Geoffrey L Smith
Journal:  Viruses       Date:  2018-02-28       Impact factor: 5.048

9.  Cost effectiveness of a web-based decision aid for parents deciding about MMR vaccination: a three-arm cluster randomised controlled trial in primary care.

Authors:  Sandy Tubeuf; Richard Edlin; Swati Shourie; Francine M Cheater; Hilary Bekker; Cath Jackson
Journal:  Br J Gen Pract       Date:  2014-08       Impact factor: 5.386

10.  The effect of measles on health-related quality of life: a patient-based survey.

Authors:  Dominic Thorrington; Mary Ramsay; Albert Jan van Hoek; W John Edmunds; Roberto Vivancos; Antoaneta Bukasa; Ken Eames
Journal:  PLoS One       Date:  2014-09-09       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.